Daily Archives: 02/11/2010

Gemcitabine En bac hearing denied by CAFC

Gemcitabine method of use patent (5,464,826) was invalidated by U.S. District Court for the Eastern District of Michigan and affirmed by CAFC (Order). Eli Lilly filed petition for panel rehearing and en bac rehearing and it was supported by BIO members amici curiae. … Continue reading

Posted in Patent case | Leave a comment